戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n elevated pulmonary vascular resistance and right heart failure.
2 d pulmonary vascular resistance and eventual right heart failure.
3 lar remodelling causing premature death from right heart failure.
4               No deaths were associated with right heart failure.
5 TV) is increasing and results in intractable right heart failure.
6 e progression of tricuspid regurgitation and right heart failure.
7 riuretic peptide levels, and the presence of right heart failure.
8 terized by pulmonary vascular remodeling and right heart failure.
9 ients with severe pulmonary hypertension and right heart failure.
10 te treatment strategies for PH and resultant right heart failure.
11 ere disorder of lung vasculature that causes right heart failure.
12 ypoxic pulmonary hypertension and ultimately right heart failure.
13 pulmonary arterial tree, eventually leads to right heart failure.
14 nt of pulmonary hypertension, and associated right heart failure.
15 n as a novel therapeutic strategy for PH and right heart failure.
16  in pulmonary vascular resistance leading to right heart failure.
17 -recognized but treatable etiology of severe right heart failure.
18  primary graft nonfunction or intraoperative right heart failure.
19 viduals present with dyspnoea or evidence of right heart failure.
20  years with death usually due to progressive right heart failure.
21 nsion with clear lungs, and disproportionate right heart failure.
22 dema (95%), and previous hospitalization for right heart failure (67%).
23 st device implantation by moderate or severe right heart failure according to criteria from the Inter
24  the case of a young man who developed acute right heart failure after combined heart and kidney tran
25 sidered when evaluating patients with severe right heart failure after PPM or ICD implantation.
26 ith change in HRQOL, baseline 3 months, were right heart failure and 3-month New York Heart Associati
27 r of systemic venous congestion, identifying right heart failure and adding incremental prognostic va
28                         Underlying causes of right heart failure and baseline hemodynamics did not pr
29  pulmonary hypertension is a risk factor for right heart failure and death after orthotopic heart tra
30 of the pulmonary vasculature that results in right heart failure and death, are usually assessed with
31 , without treatment, typically progresses to right heart failure and death.
32                 Untreated, PAH progresses to right heart failure and death.
33 ion (IPAH), a devastating disease leading to right heart failure and death.
34 ling of the pulmonary arteries, resulting in right heart failure and death.
35  relentlessly progressive disease leading to right heart failure and death.
36 nt, the disorder progresses in most cases to right heart failure and death.
37 a progressive disease that ultimately causes right heart failure and death.
38 arrowing of pulmonary arteries, resulting in right heart failure and death.
39 y vascular resistance, ultimately leading to right heart failure and death.
40 reased work of the right ventricle may cause right heart failure and liver congestion.
41 evealed a combination of left heart failure, right heart failure and moderate-to-severe tricuspid reg
42 c abnormalities that reflect the severity of right heart failure and predict adverse outcomes in pati
43 emodeling that can subsequently culminate in right heart failure and premature death.
44 lier diagnosis and noninvasive monitoring of right heart failure and pulmonary hypertension that will
45 cise intolerance, frequent hospitalizations, right heart failure and reduced survival.
46  lung inflammation, vascular remodeling, and right heart failure and reverses hypoxic pulmonary hyper
47 ions primarily arrhythmias, thromboembolism, right heart failure and, in a subset of patients, pulmon
48 y vascular resistance, eventually leading to right-heart failure and death.
49      Lower extremity edema, venous stenosis, right heart failure, and deep venous thrombosis occurred
50 art tolerance, predict decompensation before right heart failure, and guide titration of device speed
51 th pulmonary hypertension, hypoxemia, and/or right heart failure, and may offer a new therapeutic app
52    The main causes of death included sepsis, right heart failure, and multiorgan failure.
53 nt with bisoprolol delays progression toward right heart failure, and partially preserves RV systolic
54 or adverse events included bleeding, stroke, right heart failure, and percutaneous lead infection.
55 nts included postoperative bleeding, stroke, right heart failure, and percutaneous lead infection.
56                  Echocardiogram showed acute right heart failure, and pulmonary perfusion scan demons
57 or outcomes, may mediate RV vulnerability to right heart failure, and represent promising candidates
58 ve clearer evidence now for predicting early right heart failure, and treating it in those patients w
59 antly left heart failure in combination with right heart failure, and tricuspid regurgitation; and (i
60        This leads to reduced cardiac output, right heart failure, and ultimately death.
61 rized by heightened ventricular interaction, right heart failure, and worsening pulmonary vascular di
62 t estimates for bleeding, stroke, infection, right heart failure, arrhythmias, and rehospitalizations
63 ic iron levels, this model developed PAH and right heart failure as a consequence of intracellular ir
64                        One patient died from right heart failure at 3 months.
65  26 critically ill adult patients with acute right heart failure defined by echocardiographic criteri
66 e pulmonary hypertension precipitating acute right heart failure, despite administration of milrinone
67 anifest pulmonary veno-occlusive disease and right heart failure, detectable at 8 months of age.
68  OF REVIEW: To review recent publications on right heart failure developing early and late after impl
69  early to remove fluid and reduce preload if right heart failure develops.
70 have provided good evidence about predicting right heart failure early after LVADs, though how to pre
71                      CS patients had a worse right heart failure-free survival rate (hazard ratio, 2.
72                                Patients with right heart failure from cor pulmonale were classified a
73 n, retroperitoneal vascular constriction and right heart failure - has shown that serotonin and tachy
74     Patients with pulmonary hypertension and right heart failure have a high risk of clinical deterio
75 k of progressive tricuspid regurgitation and right heart failure in patients with moderate or lesser
76                                              Right heart failure is a cause of morbidity and mortalit
77                                              Right heart failure is an important cause of morbidity a
78 pertension, along with frequently associated right heart failure, is extremely challenging.
79 ure early after LVADs, though how to predict right heart failure late after LVAD is still unclear as
80 sist device (CF-LVAD) may contribute to late right heart failure (LRHF).
81 cyclin can be life-saving when perioperative right heart failure occurs due to exacerbation of pulmon
82  determined to be the direct cause of death (right heart failure or sudden death) in 37 (44%) patient
83 d more severe disease as indicated by recent right heart failure (OR, 3.3 [95% CI, 2.8-3.9]) or respi
84                   Bisoprolol delayed time to right heart failure (P<0.05).
85 nt ischemic attack, LVAD thrombosis, or late right heart failure rates by 12 months on LVAD support.
86 ents with PAH and 75.7% of those who died of right heart failure received parenteral prostanoid thera
87 evices is associated with improved outcomes, right heart failure remains a considerable challenge.
88                   Despite improved outcomes, right heart failure remains a significant challenge to s
89 ention that left heart failure has received, right heart failure remains understudied both at the pre
90 perience progressive symptoms of dyspnea and right heart failure resulting in significant morbidity a
91                                        Acute right heart failure (RHF) after left ventricular assist
92                      A revised definition of right heart failure (RHF) for the Society of Thoracic Su
93                         Our understanding of right heart failure (RHF) has lagged behind and many pro
94 amine reduces the incidence of postoperative right heart failure (RHF) in pediatric heart transplant
95                                              Right heart failure (RHF) is associated with worse clini
96                             Background Early right heart failure (RHF) occurs commonly in left ventri
97                 Our current understanding of right heart failure (RHF) post-left ventricular assist d
98 o associated with increased unadjusted early right heart failure (RHF).
99            Twelve patients died or developed right heart failure secondary to pulmonary hypertension
100       One of the deaths was from progressive right heart failure secondary to pulmonary hypertension
101 cured from explanted hearts of patients with right heart failure served as novel comparison samples.
102 d 1.10 (1.04-1.17), respectively, along with right heart failure symptoms of 2.03 (1.14-3.60), while
103                                    1) How is right heart failure syndrome best defined?
104 th respect to medical therapies for treating right heart failure, there is evidence for the use of bo
105 ar and biventricular assist devices, such as right heart failure, valvular regurgitation, cardiac arr
106  embolism-induced pulmonary hypertension and right heart failure was also tested.
107 <0.001), and the incidences of pneumonia and right heart failure were lower than those in the CS grou
108 s with dyspnea, exercise intolerance, and/or right heart failure who have elevated pulmonary artery s
109 ped for treating patients with severe TR and right heart failure with prohibitive surgical risk.
110 animals after inducing an acute air embolism right heart failure, with all animals recovering stabili
111 ications (one constrictive pericarditis, two right heart failures without underlying infection, and o

 
Page Top